다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Pear Therapeutics Inc (PEAR)
Pear Therapeutics Inc (PEAR) 뉴스

PEAR

Pear Therapeutics (PEAR)

Pear Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PEAR

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/05/03	02:37	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/13	05:34	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/11	05:37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/08	00:33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/08	00:30	Business Wire	Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/04	05:05	GlobeNewswire Inc.	Sight Sciences Appoints Ali Bauerlein as Chief Financial Officer	NASDAQ:PEAR	Pear Therapeutics Inc
2023/04/01	05:04	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/03/17	22:15	Business Wire	Pear Therapeutics Announces Process Exploring Strategic Alternatives	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/27	22:00	Business Wire	Pear Therapeutics to Participate in 43rd Annual Cowen Healthcare Conference	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/25	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/10	06:43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/02/02	22:00	Business Wire	Pear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/26	22:00	Business Wire	Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06:08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/25	06:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/19	07:02	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/18	22:00	Business Wire	Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/17	22:00	Business Wire	Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/12	22:00	Business Wire	California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/11	06:21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/10	22:00	Business Wire	Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/05	06:21	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/04	22:00	Business Wire	Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/04	20:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PEAR	Pear Therapeutics Inc
2023/01/03	21:38	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:PEAR	Pear Therapeutics Inc

검색 관련기사 보기:NASDAQ:PEAR

1 2 3 4 5 6 다음 >>

Stonebridge Preferred In...

Wisdomtree India Ex stat...

VPC Impact Acquisition

New Placer Dome Gold

Invesco Trust Invesco Do...

Vecima Networks

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관